The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia

I. A. Ilyuk (Vinnitsa, Ukraine)

Source: Annual Congress 2005 - Exploring alternative mechanisms and treatments
Session: Exploring alternative mechanisms and treatments
Session type: Thematic Poster Session
Number: 3709
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. A. Ilyuk (Vinnitsa, Ukraine). The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia. Eur Respir J 2005; 26: Suppl. 49, 3709

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 669s
Year: 2006

The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group
Source: Eur Respir J 2007; 30: Suppl. 51, 548s
Year: 2007

The usage of laferon in treatment of patients with community acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007

Using roncoleukine in basic therapy of patients with community acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 443s
Year: 2002

Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005

The general evaluation of community acquired pneumonia patients treated in our clinic
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008


The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Clinical presentation and evolution of community acquired pneumonia in older patients
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012


Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization
Source: Eur Respir J 2006; 28: Suppl. 50, 166s
Year: 2006

Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012


Quality-indicators and prognostics in CAP in three populations
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001



Influence of medical comorbidities in patients with community acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Cytokine-based prediction of aetiology in community acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007


Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010